AAPG Competitors & Alternatives
Compare Ascentage Pharma Group International with similar stocks in the same industry
Biotechnology
AAPG
Main Stock$14.62
Tradestie Score
43
Market Cap
$3.68B
Revenue Growth
0.3%
Analyst Upside
+204.4%
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AUPH
Aurinia Pharmaceuticals Inc
|
$15.73
|
$1.50B | 7.0 | 55 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$20.00
|
$1.50B | - | 38 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$30.29
|
$1.49B | - | 55 | Compare |
|
RCUS
Arcus Biosciences, Inc.
|
$17.43
|
$1.43B | - | 42 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$11.37
|
$1.42B | - | 43 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$9.45
|
$1.35B | - | 63 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$26.15
|
$1.32B | - | 49 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$16.66
|
$1.29B | - | 32 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$26.68
|
$1.29B | - | 48 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.09
|
$1.29B | - | 69 | Compare |
More AAPG Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2834)
216 stocks in this industry